F-1: Australian Oilseeds: Selling Shareholders Register 165K Shares

Sentiment:

Registration Statement (Form F-1) for Resale of Securities


Australian Oilseeds Holdings Limited files an F-1 registration statement for the resale of up to 165,000 ordinary shares by existing selling shareholders, with no proceeds going to the company.

Delay expectedThe principal and accrued interest for the First Promissory Note to American Physicians, LLC are now past due.The Second Promissory Note to American Physicians, LLC has structured payments, with USD$615,000 due as of June 30, 2025, and the remaining USD$335,000 due within 6 months, indicating a managed repayment schedule likely due to prior or ongoing financial constraints.
Capital raiseThe company has the ability to draw down an additional US$6 million of redeemable debentures from existing PIPE investors.The company has an executed US$50 million Equity Line of Credit (ELOC) that can be drawn upon once the registration statement for the ELOC is lodged.The company's ability to continue as a going concern is dependent upon raising additional funds with its financiers and investors.
Worse than expectedGross profit decreased by 41.48% (AUD$2.45 million) in FY2025 despite a 23.64% increase in sales revenue, indicating significant margin compression due to rising costs.Cost of sales increased by 37.5% (AUD$10.43 million) in FY2025, primarily due to increased input costs (raw material, packing, labor) without a corresponding increase in sales price.The net current liability position worsened to AUD$13.06 million in FY2025 from AUD$6.97 million in FY2024, indicating deteriorating short-term financial health.Net cash outflows from operating activities were AUD$966,511 for fiscal year 2025, demonstrating that core operations are not self-sustaining.The company explicitly states "substantial doubt about the Company's ability to continue as a going concern" in its financial statements.

Summary

  • Australian Oilseeds Holdings Limited manufactures and sells chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds, operating the largest cold pressing oil plant in Australia.
  • The company's Ordinary Shares and Warrants are listed on The Nasdaq Capital Market under the symbols COOT and COOTW, respectively, following a business combination consummated on March 21, 2024.
  • Sales revenue increased by AUD$7.97 million (23.64%) to AUD$41.70 million for the fiscal year ended June 30, 2025, compared to AUD$33.73 million in the prior year.
  • Gross profit decreased by AUD$2.45 million (41.48%) to AUD$3.46 million for FY2025, primarily due to a 37.5% increase in cost of sales without a corresponding increase in sales price.
  • The company reported a net loss of AUD$1.46 million for FY2025, a significant reduction from the AUD$21.23 million loss in FY2024 (which included a large recapitalization expense).
  • The net current liability position worsened to AUD$13.06 million as of June 30, 2025, from AUD$6.97 million in FY2024.
  • Net cash outflows from operating activities were AUD$966,511 for FY2025, compared to AUD$2.18 million outflows in FY2024.
  • The company's ability to continue as a going concern is dependent on generating sufficient cash from operations and securing additional funding, including an unused AUD$6.78 million facility from Commonwealth Bank and potential US$6 million redeemable debentures or a US$50 million Equity Line of Credit (ELOC).
  • Selling shareholders are offering up to 165,000 ordinary shares, and the company will not receive any proceeds from these sales.

Sentiment

Score: 3

Explanation: While sales revenue increased and the net loss decreased (partially due to a one-off recapitalization expense in the prior year), the company faces severe liquidity issues, a worsening net current liability position, negative operating cash flow, and explicit substantial doubt about its ability to continue as a going concern. The reliance on future capital raises and the past-due promissory notes indicate significant financial distress, despite strategic growth plans and market positioning.

Positives

  • Sales revenue increased by 23.64% to AUD$41.70 million in FY2025, demonstrating growth in market penetration.
  • Retail oils revenue surged by 58.4% (AUD$7.33 million) in FY2025, driven by supply contracts with major Australian supermarket chains like Costco, Woolworths, and Coles, and the development of new SKUs.
  • High protein meals revenue increased by 18.4% (AUD$1.69 million) in FY2025, reflecting growing market awareness and demand for the company's high-quality, chemical-free products.
  • Net loss for FY2025 significantly reduced to AUD$1.46 million from AUD$21.23 million in FY2024, although the prior year included a substantial recapitalization expense.
  • Cash and cash equivalents increased to AUD$2.31 million in FY2025 from AUD$0.51 million in FY2024.
  • The company has regained compliance with Nasdaq's minimum bid price requirement and the equity rule, subject to a one-year monitoring period.
  • An unused AUD$6.78 million facility from Commonwealth Bank of Australia and access to potential US$6 million redeemable debentures or a US$50 million Equity Line of Credit provide potential liquidity sources.
  • The company is committed to sustainable, chemical-free, non-GMO products and regenerative farming practices, aligning with growing consumer and industry trends.
  • Operates as the largest cold pressing oil plant in Australia with a processing capacity of over 70,000 metric tons per annum, and partially utilizes renewable solar energy, aiming for carbon neutrality.

Negatives

  • Gross profit decreased by 41.48% (AUD$2.45 million) in FY2025, indicating significant pressure on profit margins.
  • Cost of sales increased by 37.5% (AUD$10.43 million) in FY2025, primarily due to rising input costs (raw material, packing, labor) without a corresponding increase in sales prices.
  • The net current liability position worsened to AUD$13.06 million in FY2025 from AUD$6.97 million in FY2024, highlighting deteriorating short-term financial health.
  • Net cash outflows from operating activities were AUD$966,511 for FY2025, indicating that core business operations are not generating sufficient cash.
  • The company's financial statements explicitly state 'substantial doubt about the Company's ability to continue as a going concern' without additional funding.
  • Promissory notes to American Physicians, LLC, including the First Promissory Note, are past due as of June 30, 2025.
  • Revenue may not achieve budget in FY2026 due to capital expenditures for facility expansion and the need to manage cash flows for legacy payments.
  • The company is highly dependent on a small group of customers, with the top five customers accounting for 62.35% of total sales in FY2025, posing a significant concentration risk.
  • Unpaid legacy costs of AUD$2.77 million, promissory notes to American Physicians LLC of AUD$1.54 million, and a convertible note to PIPE Investor ARENA of AUD$1.17 million remain outstanding as of June 30, 2025.
  • Management has limited experience in operating a public company, which could lead to challenges in regulatory compliance and investor relations.
  • The business model is capital-intensive, and there is no assurance that additional capital can be raised on attractive terms, if at all.

Risks

  • The company's stock price may be volatile, and purchasers of Ordinary Shares could incur substantial losses.
  • There is a risk of being unable to maintain the listing of securities on Nasdaq or any other stock exchange, which could adversely affect stock price and liquidity.
  • Principal shareholders will continue to have significant influence over the election of the board of directors and approval of significant corporate actions.
  • The company could be subject to securities class action litigation, which would result in substantial costs and diversion of management's attention.
  • Reliance on research and reports from securities or industry analysts means a lack of coverage or unfavorable research could cause the market price and trading volume to decline.
  • The company does not expect to pay dividends in the foreseeable future, requiring investors to rely solely on price appreciation for returns.
  • Future sales of substantial amounts of Ordinary Shares by the company or existing shareholders could adversely affect the market price.
  • As an emerging growth company, reduced reporting requirements may make Ordinary Shares less attractive to some investors.
  • Anti-takeover provisions in the company's corporate documents could delay or prevent an acquisition.
  • Significant dependence on revenues from product sales means results of operations could be negatively impacted if unable to sell sufficient products at satisfactory margins.
  • Lack of product and business diversification makes the company susceptible to fluctuations in the agricultural industry.
  • Dependence on contracts with local and regional farmers for oilseeds means loss or quality issues could materially adversely affect the business.
  • A material concentration of revenue from a small group of customers poses a risk if any of these customers are lost or sales decline.
  • The company faces risks related to global, federal, state, and local regulations, including trade restrictions, food safety, sustainability, and environmental laws.
  • Operations are inherently subject to changing conditions, such as unfavorable weather and environmental conditions, which can affect profitability and production.
  • Disruptions in water and power supply may adversely affect the company's and its suppliers' operations.
  • Operating results may fluctuate due to variations in product demand, price changes, and increases in oil seed and utility costs.
  • Revenue may not achieve budget in FY2026 due to capital expenditure for facility expansion and managing cashflows towards legacy payments.
  • Failure to effectively promote the brand could materially and adversely affect business, financial condition, and results of operations.
  • Inability to hire and retain qualified personnel, especially key personnel like Gary Seaton, could adversely affect growth and business objectives.
  • The company may be subject to claims, litigation, or regulatory actions, with uncertain outcomes and potential significant costs.
  • The retail price of products may be subject to control by government authorities, potentially reducing revenue and profitability.
  • Failure to obtain and maintain required permits and licenses could severely disrupt business operations.
  • Adverse publicity associated with products, raw materials, or suppliers/customers could harm reputation and operating results.
  • Inability to develop new products successfully could adversely affect business and financial condition.
  • Business operations and international expansion are subject to geopolitical risks, supply chain disruptions, and inflation.
  • Risks of natural disasters, acts of God, and epidemics could severely disrupt business operations.
  • Product contamination could lead to product liability claims and recalls.
  • Failure to compete effectively in competitive markets could lead to lower revenues and higher costs.
  • Management has limited experience in operating a public company, potentially leading to challenges in regulatory oversight and reporting.
  • The company will incur significant increased expenses and administrative burdens as a public company.
  • The company's business model is capital-intensive, and inability to raise additional capital could materially and adversely affect operations.
  • The company has a history of net losses and may not be able to achieve or return to profitability.
  • The company may redeem unexpired Warrants prior to their exercise at a time that is disadvantageous to Warrant holders.
  • The warrant agreement designates specific courts as the sole and exclusive forum for certain actions, potentially limiting warrant holders' ability to obtain a favorable judicial forum.
  • The company could be treated as a Passive Foreign Investment Company (PFIC) for U.S. federal income tax purposes, leading to adverse tax consequences for U.S. Holders.

Future Outlook

The company plans to expand its existing cold-pressing capacity from 33,000 to 70,000 metric tons per annum and construct an additional larger multi-seed crushing plant in Queensland to become the largest cold-pressed producer in the Oceanic/APAC region. It aims to achieve carbon neutrality, aligning with UN Sustainable Development Goals. However, revenue for FY2026 may not meet budget due to capital expenditures for facility expansion and the need to manage cash flows for legacy payments. The company's continued operation is contingent on generating sufficient cash from business activities and securing additional long-term debt or equity funding.

Management Comments

  • "Transitioning from a fossil fuel economy to a renewable and chemical free economy is the solution to many health problems the world is facing presently."
  • "Committed to working with suppliers and customers to eliminate chemicals from the edible oil production and manufacturing systems to supply quality products such as non-GMO oilseeds and organic and non-organic food-grade oils to customers globally."
  • "Farming must be performed in a more nature-friendly, biodiversity-supporting manner."
  • "The Company believes its relationship with its employees and contractors is cooperative and its employees and contractors share the same goals as management to industrialize oilseeds, making the products available worldwide."
  • "As the Company expands, it believes it will be able to source personnel that can contribute to the technical, marketing and business development aspects of the company."

Industry Context

The company operates within the global edible oils and protein meals market, which is experiencing increasing demand for healthy, chemical-free, non-GMO, and sustainably produced products. Leveraging Australia's significant role in global canola seed trade, the company is strategically positioned to supply the expanding consumer export markets in the Asia-Pacific region and meet domestic demand. Its focus on regenerative farming practices and a commitment to carbon neutrality aligns with broader industry trends towards environmental sustainability, differentiating it from traditional agricultural systems. The planned expansion aims to capitalize on these trends and establish the company as a leading cold-pressed producer in the Oceanic/APAC region.

Comparison to Industry Standards

  • The company states it has grown to be the largest cold pressing oil plant in Australia, processing strictly GMO-free conventional and organic oilseeds, indicating a leading position in its niche within the Australian market.
  • Its current processing capacity of over 70,000 metric tons per annum for canola, safflower, and sunflower seeds positions it as a significant player in the Australian oilseed crushing industry.
  • Australia's contribution of 15-20% to the global canola seed trade provides a strong regional advantage for the company to supply rapidly expanding consumer export markets in Asia-Pacific.
  • The company's cold pressing methods are highlighted as superior to conventional solvent-based extraction (e.g., using hexane), as they retain more nutritional values, antioxidants, and healthy omega fatty acids, appealing to health-conscious consumers.
  • Good Earth Growers, a strategic partner and exclusive canola seed supplier, is noted as the first grain producer in Australia to be certified Chemical Free Farmers, setting a high standard for raw material quality and sustainability.
  • The partial adoption of renewable solar energy, abating 42.2 metric tons of CO2 per month with 568-kilowatt peak solar power, demonstrates a commitment to environmental sustainability that exceeds many industry peers and aligns with global carbon reduction goals.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Co-Chief Executive Officer and DirectorN/AJamie Mohammed Zamal2025-11-05Appointment by the Board.
Group Chief Financial Officer (AOI) / Financial Controller (Energreen Nutrition Australia Pty Ltd.)N/AAmarjeet Singh2025-02-28Appointment to the role.
Chief Financial OfficerBob WuN/A2025-02-01Resignation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Board of Directors consists of five directors: Gary Seaton (Co-CEO & Chairman), Jamie Mohammed Zamal (Co-CEO & Director), Gowri Shankar (Independent Director, Compensation Committee Chair), Long (Leo) Yi (Independent Director, Audit Committee Chair), and Elena Cozneac (Independent Director, Nominating and Corporate Governance Committee Chair).2025-11-05Maintains a mix of executive and independent directors, with independent directors chairing key committees. However, as a controlled company, it may elect to rely on Nasdaq exemptions from certain corporate governance requirements, potentially reducing shareholder protections.
Controlled Company StatusThe company is a controlled company as defined under Nasdaq Stock Market Rules because JSKS Enterprises (majority shareholder, owned by Gary Seaton) holds more than 50% of the voting power. The company intends to take advantage of certain exemptions from corporate governance requirements.N/AAllows the company to forgo certain Nasdaq requirements such as a majority independent board, independent compensation committee, and independent nominating committee. This could limit the protections afforded to shareholders compared to companies subject to all Nasdaq corporate governance requirements.
Policy AdoptionThe Board of Directors adopted a compensation clawback policy.2024-04-10Enhances corporate accountability by allowing the company to recover erroneously awarded incentive compensation from current and former executive officers under specific conditions.
Policy AdoptionThe company has an Insider Trading Policy that prohibits executive officers and directors from engaging in short sales, short sales against the box, put and call options, and hedging transactions involving company securities.N/AAims to prevent speculative trading and potential conflicts of interest by insiders, promoting fair and orderly markets for the company's securities.
Committee StructureThe Board has an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee, each comprised solely of independent directors.N/AProvides independent oversight for critical areas such as financial reporting, executive compensation, and director nominations, despite the company's controlled company status.

Legal Proceedings

  • The company is not currently a party to any legal proceedings that, if determined adversely, would individually or in the aggregate have a material adverse effect on its business or financial condition.
  • The filing notes that securities class action litigation has often been brought against companies following a decline in stock price and against SPACs post-merger, and that the company could face such litigation in the future, resulting in substantial costs and diversion of management's attention.

Related Party Transactions

  • **Energreen Nutrition Australia Pty Ltd. (controlled by Gary Seaton)**: Significant transactions including purchases of seed (AUD$14.38M in FY2025), purchases of oils (AUD$0.76M in FY2025), sales of meals (AUD$5.82M in FY2025), other sales (AUD$0.22M in FY2025), management fees (AUD$0.36M in FY2025), and lease payments (AUD$0.02M in FY2025).
  • **Soon Soon Oilmills Sdn Bhd. (Gary Seaton has 20% share)**: Purchases of oils (AUD$0.70M in FY2025).
  • **Sunmania Pty Ltd.** : Other sales (AUD$32,868 in FY2025) and lease payments (AUD$77,000 in FY2025).
  • **JSKS Enterprises Pty Ltd. (trustee of Gary Seaton Family Trust)**: A related party loan amounting to AUD$4,998,512 was converted into equity shares during FY2025. Previously, AUD$4.53 million was owed as of June 30, 2024, with a 6% annual interest rate.
  • **Energreen Nutrition Australia Pty Ltd. Loan (payable)**: AUD$6.32 million total (AUD$5.73 million current, AUD$0.59 million non-current) as of June 30, 2025, with a 6% annual interest rate.
  • **CQ Oilseeds Pty Ltd. loan (payable)**: AUD$59,371 (non-current) as of June 30, 2025, which is an interest-free loan.
  • **Energreen Nutrition Related party loan receivable**: AUD$633,733 (current) as of June 30, 2025.
  • **Trade payable (related party)**: Energreen Nutrition Australia Pty Ltd. (AUD$5.56M), Soon Soon Oilmills (AUD$153,105), and Sunmania Pty Ltd (AUD$38,500) as of June 30, 2025.
  • **Trade receivable (related party)**: Energreen Nutrition (AUD$30,040) and Sunmania Pty Ltd (AUD$14,346) as of June 30, 2025.
  • **Promissory Notes to American Physicians LLC**: AUD$1,538,322 (current) as of June 30, 2025, with the First Promissory Note's principal and accrued interest now past due.
  • **Escrow Agreement**: Arena (PIPE) lodged an event of default and unilaterally withdrew USD$1 million from an Escrow Account with American Physicians (AP). The company was not a party to this escrow account and is reviewing the impact on its convertible note liability.

Stakeholder Impact

  • **Shareholders**: Face potential dilution from future capital raises (ELOC, debentures), significant volatility in share price, and no anticipated dividends. The concentrated voting power of principal shareholders could influence corporate actions. The current offering is a resale by existing shareholders, providing no direct capital injection to the company.
  • **Employees**: The company believes its relationship with employees is cooperative, and expansion plans may lead to increased hiring. However, the inability to attract and retain qualified personnel is identified as a risk to growth.
  • **Customers**: Benefit from increased sales to existing customers and new contracts with major supermarket chains. However, the high dependence on a small group of customers creates a risk if these relationships deteriorate or sales decline. The focus on chemical-free, non-GMO products aligns with growing consumer demand for healthy options.
  • **Suppliers (Farmers)**: The company's dependence on contracts with local and regional farmers for oilseeds means their operations are critical. Issues with contract renewal, quality, or supply could adversely impact the company. The commitment to sustainable farming practices benefits these growers.
  • **Creditors**: Face significant risk due to the company's substantial net current liabilities, negative operating cash flow, and explicit 'going concern' doubt. Promissory notes are past due, and while there's an unused bank facility, all bank borrowings are currently classified as current pending covenant compliance confirmation. The withdrawal of funds from an escrow account by a PIPE investor also adds uncertainty regarding debt obligations.

Next Steps

  • Lodge the registration statement for the US$50 million Equity Line of Credit (ELOC).
  • Convert additional debt and increase revenues to maintain minimum equity value, as per Nasdaq compliance plan.
  • Continue efforts to achieve and maintain compliance with all Nasdaq listing requirements, subject to a one-year monitoring period until November 4, 2026.
  • Expand the Cootamundra facility for increased capacity or overhaul/spec adjustment.
  • Construct a new larger multi-seed crushing plant in Queensland to become the largest cold-pressed producer in the Oceanic/APAC region.
  • Launch additional product lines and increase production to meet demand and reach revenue goals while maintaining quality and sustainability.
  • Achieve the transfer of all of Energreen's equity interests in CQ Oilseeds to the Company, making CQ Oilseeds a wholly-owned subsidiary.
  • Achieve the transfer of the Australian Crushing Plant Lease from Energreen to CQ Oilseeds.
  • Ensure CQ Oilseeds grants a first priority security interest in all its assets to the Purchaser.
  • Issue a Penny Warrant to the Purchaser if certain conditions related to CQ Oilseeds transfer and security are not met.
  • Enter into a Registration Rights Agreement with the Purchaser for Penny Warrant shares.
  • Provide information and documentation related to the progress of the CQ Oilseeds Facility construction upon request.
  • Continue making monthly payments of USD$100,000 to Ellenoff Grossman & Schole LLP (EGS) until December 2025 (with USD$200,000 in December 2025).
  • Begin paying USD$35,000 per month to IBankers (IBS) from July 2025 onwards, with potential increases after EGS outstanding are fully repaid.
  • Review the Securities Purchase Agreement with Arena (PIPE) to confirm whether the liability pertaining to outstanding convertible notes will be extinguished due to the withdrawal of funds from an Escrow Account.

Key Dates

DateDescription
2022-12-07Business Combination Agreement announced.
2022-12-29Company incorporated in the Cayman Islands.
2023-08-23Securities Purchase Agreement with Arena Investors, LP.
2023-10-31Amendment No. 1 to Securities Purchase Agreement.
2023-12-04Amendment No. 2 to Securities Purchase Agreement.
2024-02-14Company drew down AUD$4,000,000 equipment loan from Commonwealth Bank of Australia.
2024-02-29Amendment No. 3 to Securities Purchase Agreement.
2024-03-21Business Combination consummated; EDOC merged into Merger Sub, and the Company acquired AOI shares.
2024-03-22Ordinary Shares and Warrants commenced trading on the Nasdaq Global Market under symbols COOT and COOTW.
2024-04-10Board of Directors adopted a compensation clawback policy.
2024-08-28Nasdaq notified the company of non-compliance with the $1 minimum bid price rule.
2024-12-06Nasdaq notified the company of non-compliance with the $10 million shareholders' equity rule.
2025-01-02Closing bid price of Ordinary Shares was at or above $1.00 per share for 15 consecutive business days, regaining bid price compliance (period from Dec 11, 2024 to Jan 2, 2025).
2025-01-20Company submitted its plan to regain compliance with Nasdaq's equity rule.
2025-01-28Company supplemented its plan for equity rule compliance.
2025-02-18Nasdaq granted an extension to May 30, 2025, to regain compliance with the equity rule.
2025-02-28Amarjeet Singh appointed Group Chief Financial Officer of AOI.
2025-05-27Nasdaq issued a notice of non-compliance with the $1.00 Minimum Bid Price requirement again.
2025-05-27Nasdaq issued a notice of delinquency in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025.
2025-05-30Company filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, regaining filing compliance.
2025-06-10Company announced failure to regain compliance with the minimum stockholders' equity requirement.
2025-06-21First payment of USD$165,000 plus accrued interest due for the Second Promissory Note to American Physicians, LLC.
2025-06-30End of fiscal year for financial reporting.
2025-07-10Company received conversion notice from Arena (PIPE) for USD 250,000 of convertible debt to Ordinary shares.
2025-07-22Nasdaq Hearings Panel held regarding equity rule non-compliance, where the company stated it had $2.6 million in shareholder equity.
2025-07-30Extraordinary general meeting of shareholders resolved to effect a reverse share split by a ratio in the range of 1 for 2 to 1 for 8.
2025-08-22Nasdaq granted the company's request for continued listing, subject to demonstrating compliance with the equity rule by September 30, 2025.
2025-09-21Second payment of USD$165,000 plus accrued interest due for the Second Promissory Note to American Physicians, LLC.
2025-09-30Deadline to regain compliance with Nasdaq's Equity Rule.
2025-10-29Nasdaq confirmed the company had regained compliance with its bid price requirement.
2025-10-29Nasdaq approved the company's application to list its securities on The Nasdaq Capital Market.
2025-10-31Company's securities were transferred to The Nasdaq Capital Market.
2025-11-04Nasdaq confirmed the company's compliance with the Equity Rule, subject to a one-year monitoring period until November 4, 2026.
2025-11-05Jamie Mohammed Zamal appointed Co-Chief Executive Officer and Director.
2025-11-24Deadline to regain bid price compliance (from May 27, 2025 notice).
2025-12-03Last reported sales price of Ordinary Shares was US$0.81 per share.
2025-12-04Date of the F-1 Registration Statement filing.
2025-12-21Remaining balance plus accrued interest due for the Second Promissory Note to American Physicians, LLC.
2025-12-31Final payment due for EGS legal fees.

Recommendation

sell

The company faces severe financial challenges, including a substantial net current liability position, negative operating cash flow, and explicit "substantial doubt about the Company's ability to continue as a going concern." While revenue growth is positive, it's overshadowed by a significant decline in gross profit margin due to rising costs and a lack of corresponding price increases. The company is heavily reliant on future capital raises (US$6M debentures, US$50M ELOC) and has past-due promissory notes, indicating a precarious liquidity situation. The current offering is a resale by existing shareholders, meaning no new capital for the company. Given the high degree of risk, the going concern uncertainty, and the need for significant external funding, a seasoned investor would likely recommend selling or avoiding the stock until financial stability is clearly demonstrated.

Keywords

Oilseeds, Cold-pressed oils, Non-GMO, Sustainable agriculture, Protein meals, Australia, Nasdaq listing, SEC F-1 filing, Financial results, Going concern, Capital raise, Corporate governance, Risk factors, Agricultural products, Edible oils, Food industry, Emerging growth company, Controlled company, Warrants, Related party transactions

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.